Skip to main navigation Skip to search Skip to main content

PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma

  • C. Simon
  • , M. J. Hicks
  • , A. J. Nemechek
  • , R. Mehta
  • , B. W. O'Malley
  • , H. Goepfert
  • , C. M. Flaitz
  • , D. Boyd
  • Department of Head and Neck Surgery
  • University of Texas MD Anderson Cancer Center
  • Dept. Otolaryngol.-Head/Neck Surg.
  • Institut für Astronomie und Astrophysik
  • Department of Pathology
  • Baylor College of Medicine
  • Department of Bioimmunotherapy
  • Dept. Otolaryngol.-Head/Neck Surg.
  • Johns Hopkins University
  • University of Texas-Dental Branch

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)1412-1419
Number of pages8
JournalBritish Journal of Cancer
Volume80
Issue number9
DOIs
StatePublished - 1999
Externally publishedYes

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Keywords

  • Invasion
  • MAPK
  • MMP-9
  • PD 098059

Cite this